41972 Federal Register / Vol. 82, No. 170 / Tuesday, September 5, 2017 / Notices 

comments and/or suggestions from the 

public and affected agencies are invited 

to address one or more of the following 

points: (1) Whether the proposed 

collection of information is necessary 

for the proper performance of the 

function of the agency, including 

whether the information will have 

practical utility; (2) The accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; (3) 

Ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (4) Ways to minimize the 

burden of the collection of information 

on those who are to respond, including 

the use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology. 

Proposed Collection Title: NCI Cancer 

Genetics Services Directory Web-Based 

Application and Update Mailer, 0925– 

0639, Extension, National Cancer 

Institute (NCI), National Institutes of 

Health (NIH). 

Need and Use of Information 

Collection: The Office of 

Communications and Public Liaison has 

created the NCI Cancer Genetics 

Services Directory on NCI’s Web site 

Cancer.gov. This directory is a 

searchable collection of information 

about professionals who provide 

services related to cancer genetics. 

These services include cancer risk 

assessment, genetic counseling, and 

genetic susceptibility testing. The 

professionals have applied to be in the 

directory using an online application 

form and have met basic criteria 

outlined on the form. 

There are currently 552 genetics 

professionals listed in the directory. 

Approximately 30–60 new professionals 

are added to the directory each year. 

The applicants are nurses, physicians, 

genetic counselors, and other 

professionals who provide services 

related to cancer genetics. The 

information collected on the application 

form includes name, professional 

qualifications, practice locations, and 

the area of specialization. The 

information is updated annually using a 

Web-based update mailer that mirrors 

the application form. 

The NCI Cancer Genetics Services 

Directory is a unique resource for cancer 

patients and their families who are 

looking for information about their 

family risk of cancer and genetic 

counseling. Collecting applicant 

information and verifying it annually by 

using the NCI Cancer Genetics Services 

Directory Web-based Application Form 

and Update Mailer is important for 

providing this information to the public 

and for keeping it current. 

OMB approval is requested for 3 year. 

There are no costs to respondents other 

than their time. The total estimated 

annualized burden hours are 180. 

ESTIMATED ANNUALIZED BURDEN HOURS

Form name Type of respondent Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden 

per response 

(in hours) 

Total annual 

burden Hours 

Web-based Application Form ............ Genetics Professional ...................... 60 1 30/60 30 

Web-based Update Mailer ................ Genetics Professional ...................... 600 1 15/60 150 

Totals .......................................... .......................................................... 660 660 ........................ 180 

Dated: August 21, 2017. 

Karla Bailey, 

Project Clearance Liaison, National Cancer 

Institute, National Institutes of Health. 

[FR Doc. 2017–18667 Filed 9–1–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Government-Owned Inventions; 

Availability for Licensing 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: Availability for licensing U.S. 

Government owned intellectual 

property for commercial development. 

FOR FURTHER INFORMATION CONTACT: 

Licensing information and copies of the 

patent applications listed below may be 

obtained by emailing the indicated 

licensing contact at the National Heart, 

Lung, and Blood, Office of Technology 

Transfer and Development Office of 

Technology Transfer, 31 Center Drive 

Room 4A29, MSC2479, Bethesda, MD 

20892–2479; telephone: 301–402–5579. 

A signed Confidential Disclosure 

Agreement may be required to receive 

copies of the patent applications. 

SUPPLEMENTARY INFORMATION: The 

inventions listed below are owned by an 

agency of the U.S. Government and are 

available for licensing in the U.S. in 

accordance with 35 U.S.C. 209 and 37 

CFR part 404 to achieve expeditious 

commercialization of results of 

federally-funded research and 

development. Foreign patent 

applications are filed on selected 

inventions to extend market coverage 

for companies and may also be available 

for licensing. Technology description 

follows. 

Hybrid Computed Tomography 

Scanning System 

Description of Technology: The 

invention relates to a combination 

hybrid computed tomography (CT) 

system that is particularly suited for 

elucidating stages in pulmonary 

diseases, notably cystic fibrosis and 

lung cancer. Improved visualization of 

lung parenchyma and the margins of 

lung cysts and lung nodules (noninvasive ‘‘virtual biopsy’’) may provide 

sufficient detail to distinguish the types 

of cystic lesions and lung nodules such 

that the typical lung tissue pathologic 

biopsy would not be needed to make a 

diagnosis. The system includes placing 

one or more x-ray detector panels near 

the patient’s body initially outside the 

view of a CT scanner and then moved 

into place for a secondary scan. An 

initial low dose scan, CT scan or X-ray, 

can be performed and if a highresolution CT scan is then necessary a 

flat panel detector is positioned near the 

area of interest. It is preferable that the 

flat panel detector be transparent to 

high-energy x-ray photons. The plurality 

of acquired images are then 

reconstructed into a low and highresolution image. 

Potential Commercial Applications: 

• Non-invasive lung biopsies 

Development Stage: 

• Early stage, no prototype. 

Inventors: Han Wen (NHLBI) 

Intellectual Property: HHS Reference 

No. E–175–2017/0–US–01 

• U.S. Provisional Patent Application 

62/546,639 filed August 17, 2017. 

mstockstill on DSK30JT082PROD with NOTICES

Federal Register / Vol. 82, No. 170 / Tuesday, September 5, 2017 / Notices 41973 

Licensing Contact: Michael 

Shmilovich, Esq, CLP; 301–435–5019; 

shmilovm@nih.gov. 

Collaborative Research Opportunity: 

The National Heart, Lung, and Blood 

Institute seeks statements of capability 

or interest from parties interested in 

collaborative research to further develop 

and evaluate, please contact Cecilia 

Pazman, Ph.D., Technology 

Development Specialist, Office of 

Technology Transfer, National Heart, 

Lung, and Blood Institute, Phone: (301) 

594–4273; pazmance@nhlbi.nih.gov. 

Dated: August 21, 2017. 

Michael Shmilovich, 

Senior Licensing and Patenting Manager, 

National Heart, Lung, and Blood Institute, 

Office of Technology Transfer and 

Development. 

[FR Doc. 2017–18670 Filed 9–1–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Deafness and 

Other Communication Disorders; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Deafness and Other Communication 

Disorders Special Emphasis Panel; Hearing 

and Balance Clinical Trial Review. 

Date: September 27, 2017. 

Time: 4:00 p.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Telephone 

Conference Call). 

Contact Person: Shiguang Yang, DVM, 

Ph.D., Scientific Review Officer, Division of 

Extramural Activities, NIDCD, NIH, 6001 

Executive Blvd., Room 8349, Bethesda, MD 

20892, 301–496–8683, yangshi@

nidcd.nih.gov. 

Name of Committee: National Institute on 

Deafness and Other Communication 

Disorders Special Emphasis Panel; U01 

Review. 

Date: September 29, 2017. 

Time: 1:00 p.m. to 2:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Telephone 

Conference Call). 

Contact Person: Kausik Ray, Ph.D., 

Scientific Review Officer, National Institute 

on Deafness and Other Communication 

Disorders, National Institutes of Health, 

Rockville, MD 20850, 301–402–3587, rayk@

nidcd.nih.gov. 

Name of Committee: National Institute on 

Deafness and Other Communication 

Disorders Special Emphasis Panel; VSL 

Clinical Trial Review. 

Date: October 5, 2017. 

Time: 11:30 a.m. to 12:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Telephone 

Conference Call). 

Contact Person: Shiguang Yang, DVM, 

Ph.D., Scientific Review Officer, Division of 

Extramural Activities, NIDCD, NIH, 6001 

Executive Blvd., Room 8349, Bethesda, MD 

20892, 301–496–8683, yangshi@

nidcd.nih.gov. 

Name of Committee: National Institute on 

Deafness and Other Communication 

Disorders Special Emphasis Panel; NIDCD 

Institutional Research Training Grant 

Review. 

Date: October 10, 2017. 

Time: 12:30 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Telephone 

Conference Call). 

Contact Person: Katherine Shim, Ph.D., 

Scientific Review Officer, Division of 

Extramural Activities, NIH/NIDCD, 6001 

Executive Blvd., Room 8351, Bethesda, MD 

20892, 301–496–8683, katherine.shim@

nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.173, Biological Research 

Related to Deafness and Communicative 

Disorders, National Institutes of Health, HHS) 

Dated: August 29, 2017. 

Sylvia L. Neal, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–18672 Filed 9–1–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Federal Emergency Management 

Agency 

[Docket ID: FEMA–2017–0019; OMB No. 

1660–0061] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request; Federal 

Assistance to Individuals and 

Households Program, (IHP) 

AGENCY: Federal Emergency 

Management Agency, DHS. 

ACTION: Notice and request for 

comments. 

SUMMARY: The Federal Emergency 

Management Agency, as part of its 

continuing effort to reduce paperwork 

and respondent burden, invites the 

general public and other Federal 

agencies to take this opportunity to 

comment on a reinstatement, without 

change, of a previously approved 

information collection for which 

approval has expired. In accordance 

with the Paperwork Reduction Act of 

1995, this notice seeks comments 

concerning the need to continue 

collecting information from individuals 

and States in order to provide and/or 

administer disaster assistance through 

the Federal Assistance to Individuals 

and Households Programs. 

DATES: Comments must be submitted on 

or before October 5, 2017. 

ADDRESSES: Submit written comments 

on the proposed information collection 

to the Office of Information and 

Regulatory Affairs, Office of 

Management and Budget. Comments 

should be addressed to the Desk Officer 

for the Department of Homeland 

Security, Federal Emergency 

Management Agency, and sent via 

electronic mail to dhsdeskofficer@

omb.eop.gov. 

FOR FURTHER INFORMATION CONTACT: 

Requests for additional information or 

copies of the information collection 

should be made to Director, Records 

Management Division, 500 C Street SW., 

Washington, DC 20472, email address 

FEMA-Information-CollectionsManagement@fema.dhs.gov or Elizabeth 

McDowell, Program Specialist, 540– 

686–3630. 

SUPPLEMENTARY INFORMATION: The 

Robert T. Stafford Disaster Relief and 

Emergency Assistance Act, 42 U.S.C. 

5121–5207 (the Act) is the legal basis for 

FEMA to provide disaster related 

assistance and services to individuals 

who apply for disaster assistance 

benefits in the event of a federally 

mstockstill on DSK30JT082PROD with NOTICES